Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Insulin resistance appears to be the best predictor of the development of diabetes in the children of patients with type 2 diabetes, but the mechanism responsible is unknown. METHODS: We performed hyperinsulinemic-euglycemic clamp studies in combination with infusions of [6,6-(2)H(2)]glucose in healthy, young, lean, insulin-resistant offspring of patients with type 2 diabetes and insulin-sensitive control subjects matched for age, height, weight, and physical activity to assess the sensitivity of liver and muscle to insulin. Proton ((1)H) magnetic resonance spectroscopy studies were performed to measure intramyocellular lipid and intrahepatic triglyceride content. Rates of whole-body and subcutaneous fat lipolysis were assessed by measuring the rates of [(2)H(5)]glycerol turnover in combination with microdialysis measurements of glycerol release from subcutaneous fat. We performed (31)P magnetic resonance spectroscopy studies to assess the rates of mitochondrial oxidative-phosphorylation activity in muscle. RESULTS: The insulin-stimulated rate of glucose uptake by muscle was approximately 60 percent lower in the insulin-resistant subjects than in the insulin-sensitive control subjects (P<0.001) and was associated with an increase of approximately 80 percent in the intramyocellular lipid content (P=0.005). This increase in intramyocellular lipid content was most likely attributable to mitochondrial dysfunction, as reflected by a reduction of approximately 30 percent in mitochondrial phosphorylation (P=0.01 for the comparison with controls), since there were no significant differences in systemic or localized rates of lipolysis or plasma concentrations of tumor necrosis factor alpha, interleukin-6, resistin, or adiponectin. CONCLUSIONS: These data support the hypothesis that insulin resistance in the skeletal muscle of insulin-resistant offspring of patients with type 2 diabetes is associated with dysregulation of intramyocellular fatty acid metabolism, possibly because of an inherited defect in mitochondrial oxidative phosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although the existence of mitochondrial abnormalities in patients with type 2 diabetes has been extensively reported during the last decade (1–5), there is no evidence that a reduced mitochondrial function is a primary factor in the pathophysiology of this disease.”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [2]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis is based on the finding that type 2 diabetics and insulin-resistant individuals with impaired glucose tolerance have ≈30% less mitochondria in their muscles than insulin-sensitive control subjects (3–7).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, lean healthy offspring of diabetic parents have a significant decrease in insulin-stimulated total body and muscle glucose disposal which is of a similar magnitude to that observed in their diabetic parents [30–32].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis is supported by in vivo reports that the incorporation of 13 C-acetate into glutamate and mitochondrial phosphorylation was approximately 30% lower in muscle of insulin-resistant versus lean individuals (81,83).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and that insulin resistance is strongly associated with increases in hepatic (HTG) and ∕ or intramyocellular lipid content”
From Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men (2006) · cites this paper as [11]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Research works printed but not linked: 1
- Luft R, Luthman H. Mitokondriernas patofysiologi: från Lufts sjukdom till åldrande och diabetes. Lakartidningen. 1993;90:2770–5. [PubMed] [Google Scholar]
Cited by
Items 601–700 of 1,020
Mitochondrial Dysfunction in Obesity and Reproduction
Das, M., Sauceda, C., & Webster, N. J. G. (2020) · Endocrinology · doi:10.1210/endocr/bqaa158 · Cited by 91
Girard, J. R., & Lafontan, M. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.04.002 · Cited by 94
Impaired Mitochondrial Function and Insulin Resistance of Skeletal Muscle in Mitochondrial Diabetes
Szendroedi, J., Schmid, A. I., Meyerspeer, M., Cervin, C., Kacerovsky, M., Smekal, G., Gräser-Lang, S., Groop, L., & Roden, M. (2009) · Diabetes Care · doi:10.2337/dc08-2078 · Cited by 83
Olsson, A. H., Yang, B. T., Hall, E., Taneera, J., Salehi, A., Dekker Nitert, M., & Ling, C. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0282 · Cited by 80
Manders, R. J., Little, J. P., Forbes, S. C., & Candow, D. G. (2012) · Nutrients · doi:10.3390/nu4111664 · Cited by 79
“Accordingly, reduced quantity and/or quality of skeletal muscle mitochondria is hypothesized to contribute to insulin resistance in older adults [88] and aging-related diseases, such as type 2 diabetes [89,90].”
BackgroundMitochondrial Respiratory Capacity and Content Are Normal in Young Insulin-Resistant Obese Humans
Fisher-Wellman, K. H., Weber, T. M., Cathey, B. L., Brophy, P. M., Gilliam, L. A. A., Kane, C. L., Maples, J. M., Gavin, T. P., Houmard, J. A., & Neufer, P. D. (2014) · Diabetes · doi:10.2337/db13-0940 · Cited by 82
Devries, M. C., Samjoo, I. A., Hamadeh, M. J., McCready, C., Raha, S., Watt, M. J., Steinberg, G. R., & Tarnopolsky, M. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2044 · Cited by 82
Pérez-Schindler, J., Summermatter, S., Salatino, S., Zorzato, F., Beer, M., Balwierz, P. J., van Nimwegen, E., Feige, J. N., Auwerx, J., & Handschin, C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00877-12 · Cited by 82
“Lower whole-body aerobic capacity, muscle mitochondrial content, and oxidative activity, which all correlate with a sedentary lifestyle, contribute to the development of metabolic disorders (9, 25, 34, 38).”
BackgroundGali Ramamoorthy, T., Laverny, G., Schlagowski, A.-I., Zoll, J., Messaddeq, N., Bornert, J.-M., Panza, S., Ferry, A., Geny, B., & Metzger, D. (2015) · Nature Communications · doi:10.1038/ncomms10210 · Cited by 74
Jiao, A., Yu, B., He, J., Yu, J., Zheng, P., Luo, Y., Luo, J., Yan, H., Wang, Q., Wang, H., et al. (2021) · Nutrition · doi:10.1016/j.nut.2021.111198 · Cited by 90
Pulmonary Arterial Hypertension: Challenges in Translational Research and a Vision for Change
Sutendra, G., & Michelakis, E. D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005428 · Cited by 82
“Indeed, suppressed oxidative phosphorylation in skeletal muscle mitochondria contributes to the metabolic syndrome (63, 64).”
BackgroundMøller, A. B., Kampmann, U., Hedegaard, J., Thorsen, K., Nordentoft, I., Vendelbo, M. H., Møller, N., & Jessen, N. (2017) · Scientific Reports · doi:10.1038/srep43775 · Cited by 82
Chen, L.-L., Zhang, H.-H., Zheng, J., Hu, X., Kong, W., Hu, D., Wang, S.-X., & Zhang, P. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.002 · Cited by 81
Lim, J. H., Lee, J. I., Suh, Y. H., Kim, W., Song, J. H., & Jung, M. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0278-4 · Cited by 81
“Because it has been reported that mitochondrial dysfunction increases intramyocellular lipid metabolites, which may activate serine/threonine kinases and repress insulin signalling by phosphorylating IRS1 [12, 33–35], we probed for the presence of lipids in oligomycin-treated C2C12 cells.”
BackgroundA shift in energy metabolism anticipates the onset of sarcopenia in rhesus monkeys
Pugh, T. D., Conklin, M. W., Evans, T. D., Polewski, M. A., Barbian, H. J., Pass, R., Anderson, B. D., Colman, R. J., Eliceiri, K. W., Keely, P. J., et al. (2013) · Aging Cell · doi:10.1111/acel.12091 · Cited by 81
“In humans, defects in skeletal muscle energy metabolism are linked to glucoregulatory dysfunction (Petersen et al., 2004) and type 2 diabetes (Lowell & Shulman, 2005), indicating that changes in muscle metabolism can Correspondence Rozalyn M. Anderson, GRECC D5214, VA Hospital, 2500 Overlook…”
BackgroundJones, T. E., Pories, W. J., Houmard, J. A., Tanner, C. J., Zheng, D., Zou, K., Coen, P. M., Goodpaster, B. H., Kraus, W. E., & Dohm, G. L. (2019) · Surgery · doi:10.1016/j.surg.2019.04.017 · Cited by 88
Jubaidi, F. F., Zainalabidin, S., Mariappan, V., & Budin, S. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176043 · Cited by 82
The metabolic syndrome: Insulin resistance
Mikhail, N. E. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0027-4 · Cited by 85
“Cellular mechanisms that trigger insulin resistance must be clarifi ed. Although muscle mitochondrial dysfunction was demonstrated in one study of insulin-resistant offspring of patients with type 2 diabetes [ 25 ], a more recent study failed to fi nd a difference in muscle mitochondrial oxidative capacity between pat…”
BackgroundDaniele, G., Eldor, R., Merovci, A., Clarke, G. D., Xiong, J., Tripathy, D., Taranova, A., Abdul-Ghani, M., & DeFronzo, R. A. (2014) · Diabetes · doi:10.2337/db13-1130 · Cited by 83
“thereby impairing insulin signaling and resulting in insulin resistance (7).”
BackgroundValdez, R. A., Greenlund, K. J., Khoury, M. J., & Yoon, P. W. (2007) · PEDIATRICS · doi:10.1542/peds.2007-1010g · Cited by 91
The Mechanism of Action of Biguanides: New Answers to a Complex Question
Magno, L. D., Pastena, F. D., Bordone, R., Coni, S., & Canettieri, G. (2022) · Cancers · doi:10.3390/cancers14133220 · Cited by 92
Lactate-induced lactylation in skeletal muscle is associated with insulin resistance in humans
Maschari, D., Saxena, G., Law, T., Walsh, E., Campbell, M. C., & Consitt, L. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.951390 · Cited by 83
“Defects in skeletal muscle mitochondria often precede the development of metabolic disease (Petersen et al., 2004; Ritov et al., 2005) and likely contributes to lactate accumulation in obese, insulin resistant individuals when pyruvate production exceeds oxidative capabilities (Avogaro et al.”
BackgroundMuscle glycogen content in type 2 diabetes mellitus
He, J., & Kelley, D. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2004 · Cited by 79
Timmons, J. A., Norrbom, J., Schéele, C., Thonberg, H., Wahlestedt, C., & Tesch, P. (2006) · Genomics · doi:10.1016/j.ygeno.2005.09.007 · Cited by 79
“There is now emerging evidence from large-scale gene expression studies that specific mitochondrial defects could represent an important factor for the development of insulin resistance and Type 2 diabetes [13,14,16,20,21,30].”
BackgroundUrolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation
Huang, J., Zhang, M.-H., Chen, Y., Sun, Y., Gao, Z., Li, Z.-J., Zhang, G., Qin, Y. H., Dai, X.-Y., Yu, X., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00919-1 · Cited by 89
“Mitophagy is closely associated with mitochondrial function and is indispensable for mitochondrial homeostasis in health and multiple disease conditions [15, 18, 19].”
BackgroundMitochondrial DNA Backgrounds Might Modulate Diabetes Complications Rather than T2DM as a Whole
Achilli, A., Olivieri, A., Pala, M., Kashani, B. H., Carossa, V., Perego, U. A., Gandini, F., Santoro, A., Battaglia, V., Grugni, V., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021029 · Cited by 79
“Mitochondrial involvement in the pathogenesis of major commonmetabolic disorders, including T2DM, stems from the observation of dysfunctions in the mitochondrial energy production machinery (OXPHOS) of many patients [7–10].”
BackgroundSkeletal Muscle Metabolic Dysfunction in Obesity and Metabolic Syndrome
Wells, G. D., Noseworthy, M. D., Hamilton, J., Tarnopolski, M., & Tein, I. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100007538 · Cited by 78
De Feyter, H. M., Lenaers, E., Houten, S. M., Schrauwen, P., Hesselink, M. K., Wanders, R. J. A., Nicolay, K., & Prompers, J. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-112318 · Cited by 77
MicroRNAs in Skin and Wound Healing
Banerjee, J., & Sen, C. K. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-083-0_26 · Cited by 86
Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes
Jin, W., & Patti, M.-E. (2009) · Clinical Science · doi:10.1042/cs20080090 · Cited by 78
Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS‐55
Collison, K. S., Saleh, S. M., Bakheet, R. H., Al‐Rabiah, R. K., Inglis, A. L., Makhoul, N. J., Maqbool, Z. M., Zaidi, M. Z., Al‐Johi, M. A., & Al‐Mohanna, F. A. (2009) · Obesity · doi:10.1038/oby.2009.58 · Cited by 80
Use of dicarboxylic acids in type 2 diabetes
Mingrone, G., Castagneto‐Gissey, L., & Macé, K. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04177.x · Cited by 82
Mitochondrial function, energy expenditure, aging and insulin resistance
Ritz, P., & Berrut, G. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(05)73654-5 · Cited by 88
“Insulin resistant offspring of type 2 diabetic patients display impaired mitochondrial energetic [43].”
BackgroundSoto-Urquieta, M. G., López-Briones, S., Pérez‐Vázquez, V., Saavedra‐Molina, A., Hernández, G. A. G., & Ramírez-Emiliano, J. (2014) · Biological Research · doi:10.1186/0717-6287-47-74 · Cited by 79
“Thus, there is sufficient evidence that obesity and diabetes induce deficiencies in ATP synthesis [4-8,24-28].”
BackgroundPredictors of Whole-Body Insulin Sensitivity Across Ages and Adiposity in Adult Humans
Lalia, A. Z., Dasari, S., Johnson, M. L., Robinson, M. M., Konopka, A. R., Distelmaier, K., Port, J. D., Glavin, M. T., Esponda, R. R., Nair, K. S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2892 · Cited by 74
“offspring of type 2 diabetes patients (25).”
BackgroundNovel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR
Maiese, K. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.179032 · Cited by 79
“Patients with Type 2 DM also have impaired skeletal muscle mitochondrial activity than those in control subjects (Petersen et al., 2004; Newsholme et al., 2012). mTOR activation blocks apoptosis to limit insulin resistance and vascular thrombosis in patients with metabolic syndrome ( Figure 1 ).”
Insulin Resistance, Prediabetes, Metabolic Syndrome: What Should Every Pediatrician Know?
Ighbariya, A., & Weiss, R. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2017.s005 · Cited by 97
“It is well established that young, lean offspring of parents with type 2 diabetes have greater intramuscular fat and lower whole body insulin sensitivity compared to their counterparts without such family history (49).”
BackgroundDiabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Potenza, M. A., Sgarra, L., Desantis, V., Nacci, C., & Montagnani, M. (2021) · Antioxidants · doi:10.3390/antiox10081257 · Cited by 87
“This last condition has been reported in patients with T2DM, in which the presence of mtDNA mutations correlates with impaired synthesis of mitochondrial proteins and down-regulation of both mitochondrial function and gene expression [176].”
BackgroundDiabetes in Patients With Idiopathic Parkinson's Disease
Becker, C., Brobert, G., Johansson, S., Jick, S. S., & Meier, C. R. (2008) · Diabetes Care · doi:10.2337/dc08-0479 · Cited by 81
Morino, K., Petersen, K. F., Sono, S., Choi, C. S., Samuel, V. T., Lin, A., Gallo, A., Zhao, H., Kashiwagi, A., Goldberg, I. J., et al. (2012) · Diabetes · doi:10.2337/db11-1391 · Cited by 77
“In this regard, recent studies show an ;35% reduction in resting muscle mitochondrial ATP production (3) and tricarboxylic acid activity (1) in young, lean IR offspring, which could be attributed to a 35% reduction in mitochondrial density (2).”
BackgroundSelf-citationIn vivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins
Jaleel, A., Short, K. R., Asmann, Y. W., Klaus, K. A., Morse, D. M., Ford, G. C., & Nair, K. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90586.2008 · Cited by 76
“MUSCLE MITOCHONDRIAL DYSFUNCTION has been reported to occur in a variety of conditions, including type 2 diabetes (1, 26, 48, 51), insulin resistance (37), obesity (27, 39), aging (36, 46), and sepsis (7, 18).”
BackgroundMaternal obesity reduces oxidative capacity in fetal skeletal muscle of Japanese macaques
McCurdy, C. E., Schenk, S., Hetrick, B., Houck, J., Drew, B. G., Kaye, S., Lashbrook, M., Bergman, B. C., Takahashi, D. L., Dean, T. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86612 · Cited by 75
Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns
Mohlke, K. L., Jackson, A., Scott, L. J., Peck, E. C., Suh, Y. D., Chines, P. S., Watanabe, R. M., Buchanan, T. A., Conneely, K. N., Erdos, M. R., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-0046-4 · Cited by 92
Fabbri, E., Chia, C. W., Spencer, R. G., Fishbein, K. W., Reiter, D. A., Cameron, D., Zane, A. C., Moore, Z. A., Gonzalez-Freire, M., Zoli, M., et al. (2017) · Diabetes · doi:10.2337/db16-0754 · Cited by 76
“However, human studies showed mitochondrial impairment in insulin-resistant offspring of patients with types 2 diabetes, suggesting that impaired oxidative capacity may drive IR (19).”
Brøns, C., Jensen, C. B., Storgaard, H., Alibegovic, A., Jacobsen, S., Nilsson, E., Astrup, A., Quistorff, B., & Vaag, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0630 · Cited by 76
Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycemic Control
Mitsuishi, M., Miyashita, K., Muraki, A., & Itoh, H. (2009) · Diabetes · doi:10.2337/db08-0949 · Cited by 74
“Moreover, reduced mitochondrial content and function in muscle have been also observed in pre-diabetic subjects with a family history of type 2 diabetes (3).”
BackgroundMarycz, K., Kornicka, K., Marędziak, M., Golonka, P., & Nicpoń, J. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12932 · Cited by 78
Mitochondria as target of endocrine-disrupting chemicals: implications for type 2 diabetes
Marroquí, L., Tudurí, E., Alonso‐Magdalena, P., Quesada, I., Nadal, Á., & dos Santos, R. S. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0362 · Cited by 77
Luan, G., Li, G., Ma, X., Jin, Y., Hu, N., Li, J., Wang, Z., & Wang, H. (2019) · Molecules · doi:10.3390/molecules24101982 · Cited by 80
“Nuclear magnetic resonance spectroscopy studies have shown that mitochondrial oxidative phosphorylation function in muscle and liver tissues of individuals with insulin resistance was significantly reduced [14].”
BackgroundKasai, S., Kokubu, D., Mizukami, H., & Itoh, K. (2023) · Biomolecules · doi:10.3390/biom13101544 · Cited by 76
“As decreased OxPhos and lipid accumulation without enhancement of systemic lipolysis and signs of inflammation have been observed in the muscles of prediabetic lean IR people of the offspring of T2D patients [21], mitochondrial dysfunction might be causative for IR.”
BackgroundWang, Z. Q., Zhang, X. H., Yu, Y., Poulev, A., Ribnicky, D., Floyd, Z. E., & Cefalu, W. T. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.09.004 · Cited by 82
“Evidence has been accumulating that insulin resistance is accompanied bymitochondrial dysfunction in skeletal muscle and liver, and that this could be the proximal cause of impaired lipid oxidation and accumulation of intramyocellular lipid [31–33].”
BackgroundYoneda, M., Hotta, K., Nozaki, Y., Endo, H., Uchiyama, T., Mawatari, H., Iida, H., Kato, S., Hosono, K., Fujita, K., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-27 · Cited by 80
“Recent studies have also shown altered expression of PPARGC1A and downstream mitochondrial target pathways in the skeletal muscle of humans with insulin resistance and diabetes [ 35- 37 ].”
BackgroundDevelopmental origins of diabetes: The role of oxidative stress
Simmons, R. A. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.03.012 · Cited by 72
“Studies using 13C and 31P magnetic resonance spectroscopy (MRS) have shown decreases in mitochondrial activity and increases in intramyocellular fat content in young insulin-resistant offspring of parents with type 2 diabetes, a group that has a strong tendency to develop diabetes later in life (92).”
BackgroundHyperglycemia-induced mitochondrial alterations in liver
Dey, A., & Swaminathan, K. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.06.007 · Cited by 78
Rabøl, R., Svendsen, P. F., Skovbro, M., Boushel, R., Haugaard, S. B., Schjerling, P., Schrauwen, P., Hesselink, M. K. C., Nilas, L., Madsbad, S., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.014 · Cited by 78
Near-infrared assessments of skeletal muscle oxidative capacity in persons with spinal cord injury
Erickson, M. L., Ryan, T. E., Young, H.-J., & McCully, K. K. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2657-0 · Cited by 75
Scatena, R., Bottoni, P., Martorana, G. E., Ferrari, F., Sole, P. D., Rossi, C., & Giardina, B. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.072 · Cited by 81
Hoeks, J., Hesselink, M. K. C., Russell, A. P., Mensink, M., Saris, W. H. M., Mensink, R. P., & Schrauwen, P. (2006) · Diabetologia · doi:10.1007/s00125-006-0369-2 · Cited by 74
“capacity, is derived from the following consecutive observations: (1) older, insulin-resistant subjects displayed decreases in mitochondrial oxidative activity and ATP synthesis [14]; (2) similar decreases were observed in young insulin-resistant offspring of patients with type 2 diabetes [3]; (3) genes involved in mi…”
BackgroundSnel, M., Gastaldelli, A., Ouwens, D. M., Hesselink, M. K. C., Schaart, G., Buzzigoli, E., Frölich, M., Romijn, J. A., Pijl, H., Meinders, A. E., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3178 · Cited by 74
Deng, X., Zhang, S., Wu, J., Sun, X., Shen, Z., Dong, J., & Huang, J. (2019) · Journal of Food Science · doi:10.1111/1750-3841.14723 · Cited by 77
The role of dietary acid load and mild metabolic acidosis in insulin resistance in humans
Williams, R. S., Kozan, P., & Samocha‐Bonet, D. (2015) · Biochimie · doi:10.1016/j.biochi.2015.09.012 · Cited by 82
Wang, J., Li, J., Zou, Y., Cheng, W., Lu, C., Zhang, L., Ge, J., Huang, C., Jin, Y. J., Lv, X., et al. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.09.029 · Cited by 78
Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy
Peterson, M. D., Gordon, P. M., Hurvitz, E. A., & Burant, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00338.2012 · Cited by 84
Effect of ICSI on gene expression and development of mouse preimplantation embryos
Giritharan, G., Li, M. W., Sebastiano, F. D., Esteban, F. J., Horcajadas, J. A., Lloyd, K. C. K., Donjacour, A. A., Maltepe, E., & Rinaudo, P. F. (2010) · Human Reproduction · doi:10.1093/humrep/deq266 · Cited by 77
“For example, it has been hypothesized as the mechanism inducing the insulin-resistant phenotype observed in offspring of patients with type 2 diabetes (Petersen et al., 2004).”
BackgroundAbulizi, A., CARDONE, R. L., Stark, R., Lewandowski, S. L., Zhao, X., Hillion, J., Ma, L., Sehgal, R., Alves, T. C., Thomas, C. J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.006 · Cited by 75
“Increased tissue TAG is a marker of hepatic insulin resistance in human subjects and rodent models of type 2 diabetes (Petersen et al., 2004; Samuel et al., 2010).”
BackgroundCrispim, D., Canani, L. H., Gross, J. L., Tschiedel, B., Souto, K. E. P., & Roisenberg, I. (2006) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2005.00249.x · Cited by 74
Lalia, A. Z., Johnson, M. L., Jensen, M. D., Hames, K. C., Port, J. D., & Lanza, I. R. (2015) · Diabetes Care · doi:10.2337/dc14-3101 · Cited by 73
“etiology of insulin resistance (1), it is possible that n-3 PUFAs may attenuate insulin resistance through their influence on mitochondria in insulin-sensitive tissues.”
BackgroundInfluentialGold, W. A., Williamson, S. L., Kaur, S., Hargreaves, I. P., Land, J. M., Pelka, G. J., Tam, P. P. L., & Christodoulou, J. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.02.012 · Cited by 73
Hénin, G., Loumaye, A., Leclercq, I. A., & Lanthier, N. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100963 · Cited by 86
“108,109 Indeed, DAG and ceramide bodies, both products of triacylglycerol oxidation, halt the translocation of glucose transporter 4 (GLUT4) into the myocyte membrane.”
BackgroundA family history of type 2 diabetes increases risk factors associated with overfeeding
Samocha‐Bonet, D., Campbell, L. V., Viardot, A., Freund, J., Tam, C. S., Greenfield, J. R., & Heilbronn, L. K. (2010) · Diabetologia · doi:10.1007/s00125-010-1768-y · Cited by 77
“The mechanisms leading to this are not entirely clear, although defects already identified in this population include a greater tendency towards insulin resistance [2, 3], pancreatic beta cell impairment [4, 5], central adiposity [6], increased inflammation [7], increased intramyocellular lipid [8] and reduced mitocho…”
BackgroundUse of in vivo magnetic resonance spectroscopy for studying metabolic diseases
Hwang, J.-H., & Choi, C. S. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.101 · Cited by 72
Rangwala, S. M., Li, X., Lindsley, L., Wang, X., Shaughnessy, S., Daniels, T. G., Szustakowski, J. D., Nirmala, N., Wu, Z., & Stevenson, S. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.126 · Cited by 77
Nonalcoholic Fatty Liver Disease
Paredes, A. H., Torres, D. M., & Harrison, S. A. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.005 · Cited by 76
Mitochondrial Plasticity in Obesity and Diabetes Mellitus
Jelenik, T., & Roden, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4910 · Cited by 73
“Young, lean, but severely insulinresistant FDR have*30% lower in vivo flux through muscular ATP synthase than insulin-sensitive otherwise matched controls in line with impaired basal mitochondrial activity (53).”
BackgroundBeta cell (dys)function in non-diabetic offspring of diabetic patients
on behalf of the RISC Investigators, Stadler, M., Pacini, G., Petrie, J. R., Luger, A., & Anderwald, C. H. (2009) · Diabetologia · doi:10.1007/s00125-009-1520-7 · Cited by 77
“First-degree relatives of type 2 diabetes patients have a lifetime risk of developing diabetes of approximately 40%, and display insulin resistance [8, 20, 21] that is associated with increased fasting plasma NEFA [8], increased intramyocellular lipid content [22] and mitochondrial dysfunction [23].”
BackgroundTrenell, M. I., Hollingsworth, K. G., Lim, E. L., & Taylor, R. (2008) · Diabetes Care · doi:10.2337/dc08-0303 · Cited by 71
“Insulin resistant people with a family history of diabetes have reduced basal mitochondrial activity in skeletal muscle compared to insulin sensitive individuals [2].”
InfluentialUncoupling Proteins: Role in Insulin Resistance and Insulin Insufficiency
B.Chan, C., & Harper, M.-E. (2006) · Current Diabetes Reviews · doi:10.2174/157339906777950660 · Cited by 71
“In muscle of insulinresistant offspring of T2DM patients, studies have revealed decreases in mitochondrial activity and increases in intramuscular fat [18].”
BackgroundDeficiency of the Mitochondrial Electron Transport Chain in Muscle Does Not Cause Insulin Resistance
Han, D.-H., Hancock, C. R., Jung, S. R., Higashida, K., Kim, S. H., & Holloszy, J. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019739 · Cited by 71
“This possibility was suggested by the finding that obese insulin resistant individuals and type 2 diabetics generally have about 30% less mitochondria in their skeletal muscles than age-matched individuals with normal insulin action [1–7].”
BackgroundLatouche, C., Heywood, S. E., Henry, S. L., Ziemann, M., Lazarus, R. M., El‐Osta, A., Armitage, J. A., & Kingwell, B. A. (2013) · Journal of Nutrition · doi:10.3945/jn.113.186775 · Cited by 76
Kemp, G. J., & Brindle, K. M. (2012) · Diabetes · doi:10.2337/db11-1725 · Cited by 68
“(19) and can be estimated in multiple studies (20,22,29)].”
BackgroundResultInfluentialGillberg, L., Jacobsen, S. C., Rönn, T., Brøns, C., & Vaag, A. A. (2013) · Metabolism · doi:10.1016/j.metabol.2013.10.003 · Cited by 76
“[2] Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI.”
BackgroundMitochondrial DNA copy number in peripheral blood in polycystic ovary syndrome
Lee, S., Chung, D. J., Lee, H.-S., Kim, T.-J., Kim, M.-H., Jeong, H. J., Im, J., Lee, D., & Lee, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.010 · Cited by 72
Lionetti, L., Mollica, M. P., Crescenzo, R., D’Andrea, E., Ferraro, M., Bianco, F., Liverini, G., & Iossa, S. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803636 · Cited by 74
Allyl isothiocyanate ameliorates insulin resistance through the regulation of mitochondrial function
Ahn, J., Lee, H., Im, S. W., Jung, C. H., & Ha, T. Y. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.05.006 · Cited by 71
“Furthermore, a decrease in mitochondrial OXPHOS, reduction inmitochondrial number and changes inmorphology have been associated with insulin resistance [6,23].”
BackgroundUsefulness of Vegetarian and Vegan Diets for Treating Type 2 Diabetes
Trapp, C., & Barnard, N. D. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0093-7 · Cited by 82
“Lowering saturated fat intake may also contribute to a decreased concentration of intramyocellular lipid, which is strongly associated with improved insulin sensitivity [48].”
BackgroundYokota, T., Kinugawa, S., Yamato, M., Hirabayashi, K., Suga, T., Takada, S., Harada, K., Morita, N., Oyama‐Manabe, N., Kikuchi, Y., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1161 · Cited by 77
“Indeed, an abundance of evidence suggests that mitochondrial function in the skeletal muscle is impaired in insulin-resistant subjects (5,7).”
BackgroundMondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling
Ahn, B., Soundarapandian, M. M., Sessions, H., Peddibhotla, S., Roth, G. P., Li, J.-L., Sugarman, E., Koo, A., Malany, S., Wang, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87382 · Cited by 70
Mangiferin modulation of metabolism and metabolic syndrome
Fomenko, E. V., & Chi, Y. (2016) · BioFactors · doi:10.1002/biof.1309 · Cited by 68
“Excess of intracellular fatty acids activates fatty acid oxidation and leads to excessive generation of peroxidation products in mitochondria [103].”
Cardiac Insulin Resistance in Heart Failure: The Role of Mitochondrial Dynamics
Saotome, M., Ikoma, T., Hasan, P., & Maekawa, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143552 · Cited by 68
“In patients with insulin resistance and T2DM, the reduced mitochondrial OXPHOS—due to mitochondrial dysfunction—promotes excess intracellular lipid metabolite accumulation (such as fatty acyl CoAs and diacylglycerol) in the skeletal muscle [58].”
BackgroundTang, R., Harasymowicz, N. S., Wu, C., Collins, K. H., Choi, Y., Oswald, S. J., & Guilak, F. (2020) · Science Advances · doi:10.1126/sciadv.aaz7492 · Cited by 75
Mitochondrial fitness and insulin sensitivity in humans
Szendroedi, J., & Roden, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1153-2 · Cited by 71
“insulin-resistant relatives of individuals with type 2 diabetes have a ∼30% lower fasting fATP, ∼80% higher intramyocellular lipid, but similar hepatocellular lipid levels compared with insulin-sensitive controls [ 41 ] (Table 1). These relatives also have reduced insulin-stimulated fATP and Pi transport into skeletal…”
BackgroundInfluentialHeilbronn, L. K., Gregersen, S., Shirkhedkar, D., Hu, D., & Campbell, L. V. (2007) · Diabetes · doi:10.2337/db06-1687 · Cited by 70
“However, the mechanism(s) responsible for these early defects in lipid metabolism is not completely elucidated, although we and others suggest that intramuscular triglyceride accumulation may occur secondary to the development of insulin resistance (3,5).”
BackgroundMinireview: Mitochondrial Energetics and Insulin Resistance
Civitarese, A. E., & Ravussin, E. (2008) · Endocrinology · doi:10.1210/en.2007-1444 · Cited by 70
Metabolic Reprogramming in Dietary Restriction
Anderson, R. M., & Weindruch, R. (2006) · Interdisciplinary Topics in Gerontology · doi:10.1159/000096554 · Cited by 67
“Studies in type 2 diabetes have implicated mitochondrial dysfunction in this disorder [74, 75] providing a link between mitochondrial function and whole-body endocrine signaling.”
BackgroundPhysiological Insights Gained from Gene Expression Analysis in Obesity and Diabetes
Keller, M. P., & Attie, A. D. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104747 · Cited by 69
“Offspring of type 2 diabetics also show a decline in mitochondrial function, along with insulin resistance and an increase in the accumulation of myocellular lipid (12, 99, 113).”
Mitochondrial function and endocrine diseases
Stark, R., & Roden, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01773.x · Cited by 75
Zorzano, A., Hernández‐Álvarez, M. I., Palacín, M., & Mingrone, G. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.017 · Cited by 75
“Thus, offspring of type 2 diabetic parents show reduced ATP synthesis [29,30], which was the first evidence that this could be an inherited”
BackgroundA Possible Link Between Skeletal Muscle Mitochondrial Efficiency and Age-Induced Insulin Resistance
Iossa, S., Mollica, M. P., Lionetti, L., Crescenzo, R., Tasso, R., & Liverini, G. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2861 · Cited by 67
Leichman, J. G., Aguilar, D. A., King, T. M., Vlada, A. C., Reyes, M., & Taegtmeyer, H. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.336 · Cited by 76
“Metabolic dysregulation, especially when the rate of fatty acid uptake exceeds the rate of fatty acid oxidation (6, 10, 29), leads to a wide range of metabolic disturbances, including fatty acyl-CoA accumulation, insulin resistance (30, 31), and triacylglycerol accumulation (32–34).”
BackgroundMechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice
Shigiyama, F., Kumashiro, N., Tsuneoka, Y., Igarashi, H., Yoshikawa, F., Kakehi, S., Funato, H., & Hirose, T. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00072.2018 · Cited by 77
“Altered mitochondrial parameters are thought to be linked to insulin resistance (45, 63).”
Background
Metadata
- Authors
- Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I.
- Affiliations
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-12
- Volume
- 350
- Issue
- 7
- Pages
- 664-671
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2995502
- OpenAlex
- W2027670788
- Cited by
- 2,193
- References
- 44
- Citations by year
- 2026: 38 · 2025: 38 · 2024: 51 · 2023: 71 · 2022: 47 · 2021: 75 · 2020: 87 · 2019: 59 · 2018: 84 · 2017: 87 · 2016: 87 · 2015: 88 · 2014: 97 · 2013: 113 · 2012: 122
- FWCI
- 101.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01-AG-23686, R01AG023686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK063192, P30DK45735, R01DK049230, R01 DK-49230, K-23 DK-02347, P30DK045735)
- National Center for Research Resources (M01RR000125, M01 RR-00125)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin resistance, type 2 diabetes, offspring of diabetic patients, mitochondrial dysfunction, oxidative phosphorylation, skeletal muscle glucose uptake, intramyocellular lipid, fatty acid metabolism, hepatic insulin sensitivity, glycerol turnover, 31P NMR, 1H NMR, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adenosine Triphosphate, Adipose Tissue, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Female, Glucose, Glucose Tolerance Test, Glycerol, Humans, Insulin, Insulin Resistance, Lipolysis, Male, Mitochondria, Magnetic Resonance Spectroscopy, Oxidative Phosphorylation, Triglycerides, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.